Dexcom
Stuart McCormack is an experienced finance professional currently serving as Senior Director of Finance at Dexcom since March 2021, having previously held the position of Finance Director. Prior to joining Dexcom, Stuart worked at Thermo Fisher Scientific as Finance Director and Senior Finance Manager from May 2017 to March 2021. Stuart's extensive career includes significant roles at Honeywell, where responsibilities spanned Corporate Controller for the UK & Ireland and various finance leadership positions across Europe and the Middle East. Earlier experience includes finance management roles at Sumerian Europe, Carillion Business Services, Alfred McAlpine, Freescale Semiconductor, and Motorola. Stuart is a Chartered Accountant, educated at the Institute of Chartered Accountants of Scotland, and holds a BA in Accountancy & Economics from the University of Strathclyde.
This person is not in any offices
Dexcom
45 followers
Founded in 1999, Dexcom, Inc. (NASDAQ: DXCM), is developing and marketing Continuous Glucose Monitoring (CGM) systems for ambulatory use by people with diabetes and by healthcare providers for the treatment of people with diabetes. The company is the leader in transforming diabetes care and management by providing CGM technology to help patients and healthcare professionals better manage diabetes.